M&T Bank’s Genomic Health, Inc. GHDX Stock Holding History

M&T Bank’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,204	Closed	-$505K	–	1703
2019 Q1	$505K	Buy	+7,204	New	+$534K	﹤0.01%	959

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

M&T Bank's GHDX Position: Q2 2019 in Review

M&T Bank sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 7,204 shares — an estimated $505K sold.

M&T Bank first reported a position in GHDX in Q1 2019 and held it in 1 quarter. The position peaked at $505K in Q1 2019. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

M&T Bank reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
M&T Bank sold 7,204 Genomic Health, Inc. shares in Q2 2019, an estimated $505K.
M&T Bank first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 1 quarter.
M&T Bank's Genomic Health, Inc. position peaked at $505K in Q1 2019.
215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on M&T Bank's 13F filing for Q2 2019, filed 12 Aug 2019.